Abstract
While medical and surgical treatment are the mainstays of therapy today, advances in molecular biology and genetics promise to dramatically change the ob/gyn's approach to these common tumors. TAP pharmaceuticals.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 26-38 |
| Number of pages | 13 |
| Journal | Contemporary Ob-Gyn |
| Volume | 45 |
| Issue number | 7 |
| State | Published - 2000 |
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Advanced and Specialized Nursing
- Maternity and Midwifery